Reports

Sale

Influenza Diagnostics Market

Global Influenza Diagnostics Market Share, Size, Growth, Analysis, Report, Forecast: By Test Type: Traditional Diagnostic Test, Molecular Diagnostic Assay; By Product: Test Kits, Instruments; By End User: Hospitals, Diagnostic Laboratories, Research Laboratory, Others; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Influenza Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Influenza Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Influenza Epidemiology (2016-2031)
    5.3    Europe Influenza Epidemiology (2016-2031)
    5.4    Asia Pacific Influenza Epidemiology (2016-2031)
    5.5    Latin America Influenza Epidemiology (2016-2031)
    5.6    Middle East and Africa Influenza Epidemiology (2016-2031)
6    Global Influenza Diagnostic Market Overview 
    6.1    Global Influenza Diagnostic Market Historical Value (2017-2023) 
    6.2    Global Influenza Diagnostic Market Forecast Value (2024-2032)
7    Global Influenza Diagnostic Market Landscape
    7.1    Influenza Diagnostic: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Influenza Diagnostic: Product Landscape
        7.2.1    Analysis by Test Type
        7.2.2    Analysis by Product
        7.2.3    Analysis by End User
8    Influenza Diagnostic Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Influenza Diagnostic Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Influenza Diagnostic Market Segmentation
    11.1    Global Influenza Diagnostic Market by Test Type 
        11.1.1    Market Overview
        11.1.2    Traditional Diagnostic Test
            11.1.2.1    Rapid Influenza Diagnostic Test (RIDT)
            11.1.2.2    Viral Culture
            11.1.2.3    Direct Fluorescent Antibody (DFA) Test
            11.1.2.4    Serological Assay
        11.1.3    Molecular Diagnostic Assay
            11.1.3.1    Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
            11.1.3.2    Nucleic Acid Sequence-Based Amplification (NASBA) Test
            11.1.3.3    Loop-Mediated Isothermal Amplification-Based Assay (LAMP)
            11.1.3.4    Simple Amplification-Based Assay (SAMBA)
            11.1.3.5    Others
    11.2    Global Influenza Diagnostic Market by Product
        11.2.1    Market Overview
        11.2.2    Test Kits
        11.2.3    Instruments
    11.3    Global Influenza Diagnostic Market by End User
        11.3.1    Market Overview
        11.3.2    Hospitals
        11.3.3    Diagnostic Laboratories
        11.3.4    Research Laboratory
        11.3.5    Others
    11.4    Global Influenza Diagnostic Market by Region
        11.4.1    Market Overview
        11.4.2    North America
        11.4.3    Europe 
        11.4.4    Asia Pacific
        11.4.5    Latin America
        11.4.6    Middle East and Africa
12    North America Influenza Diagnostic Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Influenza Diagnostic Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Influenza Diagnostic Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Influenza Diagnostic Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Influenza Diagnostic Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    Abbott Laboratories
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Becton, Dickinson and Company
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Coris BioConcept
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    DiaSorin SpA
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    F. Hoffmann-La Roche Ltd.
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Luminex Corporation
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Meridian Bioscience Inc.
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Quidel Corporation
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    Sekisui Diagnostics
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Thermo Fisher Scientific Inc.
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    Hologic, Inc.
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
24    Influenza Diagnostic - Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global market size attained a value of USD 850.85 million in 2023.

The market is further expected to grow at a CAGR of 9% during the forecast period of 2024-2032 to reach USD 1,847.96 million by 2032.

The major growth drivers of the market include the accelerating prevalence of influenza, the rise in research funding for influenza diagnostics, and the increasing demand for faster diagnosis and management of the disease.

The key trends guiding the market growth include the rising funding for influenza diagnosis, research, and treatment.

The major regional markets include North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The test types include traditional diagnostic test and molecular diagnostic assay.

The product types in the market comprise of test kits and instruments.

The end-users in the market include hospitals, diagnostic laboratories, and research laboratory, among others.

The key players in the market include Abbott Laboratories, Becton, Dickinson and Company, Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche Ltd., Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, Thermo Fisher Scientific Inc., and Hologic, Inc., among others.

Purchase Full Report

Datasheet

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER